Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Wristband Sensor Provides All-In-One Monitoring for Diabetes and Cardiovascular Care

By HospiMedica International staff writers
Posted on 17 Jul 2025

Diabetes management is a complex and evolving challenge, particularly when it comes to accurately tracking and understanding how various factors affect blood sugar levels and overall health. More...

Traditional glucose monitoring systems often fail to account for other key factors that influence diabetes progression, such as diet, alcohol intake, exercise, and stress. Additionally, people with diabetes are at higher risk for cardiovascular diseases, which are not always monitored continuously outside of a clinical setting. Researchers have now developed a wearable wristband that tracks glucose levels along with other key chemical and cardiovascular signals in real time, enabling all-in-one monitoring for diabetes and cardiovascular care.

The solution, developed by researchers at UC San Diego (La Jolla, CA, USA), integrates several advanced technologies into a single wearable device. The wristband uses a microneedle array that painlessly samples interstitial fluid to measure glucose, lactate, and alcohol levels through three enzymes embedded within the microneedles. Additionally, it employs ultrasonic sensors to monitor blood pressure and arterial stiffness, while ECG sensors measure heart rate. The device is linked to a smart display that shows real-time data streams from the sensors, allowing wearers to see how daily activities, such as meals and exercise, affect their glucose and cardiovascular responses. The wristband is designed to be flexible, lightweight, and easy to replace, supporting longer-term use without the risk of infections or allergic reactions.

The wristband was tested and validated through comparisons with commercial devices for glucose, alcohol, and lactate monitoring. The findings, published in Nature Biomedical Engineering, confirmed that the wristband provided accurate, real-time tracking of glucose, blood pressure, heart rate, and arterial stiffness. The device showed a strong correlation with blood glucose meters, continuous glucose monitors, breathalyzers, and blood lactate meters. These results demonstrate the potential for the wristband to offer a comprehensive physiological snapshot and help identify dangerous trends before they escalate. Going forward, the researchers plan to expand the system to include additional biomarkers, make it powered by sweat or sunlight, and integrate machine learning to analyze the collected data.

“Comprehensive and effective management of diabetes requires more than just a single glucose reading,” said An-Yi Chang, a postdoctoral researcher at UC San Diego and co-first author on the study. “By tracking glucose, lactate, alcohol, and cardiovascular signals in real time, this pain-free wristband can help people better understand their health and enable early action to reduce diabetes risk.”

Related Links:
UC San Diego


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.